Genetical and immunological aspects of pathogenesis and medical treatment of chronic inflammatory diseases of the uterus and adnexa uteri

The research presents the first complex clinical estimation of the women with chronic inflammatory diseases of the uterus and adnexa uteri by new immunological and genetic methods of study. Risk prognostic factors of the chronic inflammatory diseases of small pelvis (CIDSP) in modern conditions are specified. For the first time the characteristic of the general immunoreactivity of organism on the basis of ELI-P-Test-1 is given, the dynamic of the serum level of first and second rate autoantibodies to the γ-IF is studied, it is also studied the allelic division of gene GPIIIa and discovered the dependence of immunoreactivity organism on the allele polymorphism of gene GPIIIa in CIDSP. We obtained that quantum medical treatment improves the recovery: corrects immunoreactivity and decreases the frequency of recurrence of chronic inflammatory diseases of the uterus and adnexa uteri.